Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DOXORUBICIN Cause Device related bacteraemia? 11 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Device related bacteraemia have been filed in association with DOXORUBICIN (Doxorubicin Hydrochloride). This represents 0.0% of all adverse event reports for DOXORUBICIN.

11
Reports of Device related bacteraemia with DOXORUBICIN
0.0%
of all DOXORUBICIN reports
0
Deaths
11
Hospitalizations

How Dangerous Is Device related bacteraemia From DOXORUBICIN?

Of the 11 reports, 11 (100.0%) required hospitalization, and 10 (90.9%) were considered life-threatening.

Is Device related bacteraemia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DOXORUBICIN. However, 11 reports have been filed with the FAERS database.

What Other Side Effects Does DOXORUBICIN Cause?

Febrile neutropenia (8,844) Off label use (7,858) Disease progression (6,165) Neutropenia (5,891) Drug ineffective (4,598) Pyrexia (3,697) Thrombocytopenia (3,638) Anaemia (3,601) Product use in unapproved indication (3,502) Nausea (2,925)

What Other Drugs Cause Device related bacteraemia?

TEDUGLUTIDE (40) CYCLOPHOSPHAMIDE (29) PREDNISONE (23) CYTARABINE (21) MYCOPHENOLATE MOFETIL (20) TACROLIMUS (20) METHOTREXATE (19) RITUXIMAB (19) DINUTUXIMAB BETA (17) ISOTRETINOIN (17)

Which DOXORUBICIN Alternatives Have Lower Device related bacteraemia Risk?

DOXORUBICIN vs DOXYCYCLINE DOXORUBICIN vs DOXYCYCLINE HYCLATE DOXORUBICIN vs DOXYCYCLINE\DOXYCYCLINE HYCLATE DOXORUBICIN vs DOXYLAMINE DOXORUBICIN vs DOXYLAMINE\PYRIDOXINE

Related Pages

DOXORUBICIN Full Profile All Device related bacteraemia Reports All Drugs Causing Device related bacteraemia DOXORUBICIN Demographics